Start with an emergency physician

See all

In this regard, Haoyue is relatively lucky. At least he can afford the high cost of treatment.

Zhou Yuan and He Jianyi breathed a sigh of relief when they saw the nurse hang the stem cell suspension on the infusion stand and start intravenous drip for Haoyue.

The two left the transplant cabin and prepared to return to the emergency department.

Liu Huimin has also been sent to the general ward. She has been on leave during this period, and her work in the hospital has been replaced by others.

He Jianyi looked at Zhou Yuan walking beside him, his heart full of shock.

"When did you learn bone marrow transplantation so well?……"

This technique is not difficult, but, like suturing, being able to do it and being able to do it at a high level are two completely different concepts.

Zhou Yuan's bone marrow transplantation technique is much better than that of doctors in the hematology and oncology departments, and is obviously at a high level...

He Jianyi estimated that if the original survival rate was only 10%, the success rate might increase to 40% if Zhou Yuan was the surgeon in charge of the bone marrow transplant!

For individuals, although this number is high, it is not terrible, after all, there is still a 60% mortality rate.

But... if we look at the group of patients undergoing bone marrow transplantation, then 30% of patients who are destined to die will be reborn!

"Zhou Yuan, how did you do it?……"He Jianyi couldn't help asking.

Zhou Yuan:"Epiphany."

He Jianyi laughed helplessly:"Since you don't want to say it, I can only assume that you have a talent... There is no other explanation. But, your talent is too terrifying!"

Zhou Yuan sighed.

It was really a sudden enlightenment.

"You said so, right, system?"

The system said perfunctorily:"Yes, yes, yes."

The two continued to walk forward. When they reached the lounge, He Jian stopped subconsciously, but Zhou Yuan continued to walk forward.

""Zhou Yuan, aren't you resting in the lounge?"

Zhou Yuan straightened the badge on his chest and said,"Teacher, I am now a resident doctor."

He Jianyi was stunned and a little surprised.

A 26-year-old resident doctor... This is really scary.

"Come on, I'll show you your office."

He Jianyi led Zhou Yuan to the public office.

Zhou Yuan paused and said,"Teacher, my office is independent.……"

He Jianyi:"Oh, independent... independent?!"

This time He Jianyi was really shocked.

He had worked in the emergency department for 20 to 30 years and was promoted to deputy chief physician before he had an office. Zhou Yuan has only been in the hospital for more than a month...

Zhou Yuan smiled and nodded, and took him to his new office.

The office was not big, about the same size as the dean's office.

He Jianyi was a little dumbfounded,"Dean Fang thinks too highly of you."

However, this was understandable.

With Zhou Yuan's surgical skills, it was not incredible to have an independent office.

"Teacher, how are you handling the new thrombolytic drug?"

Zhou Yuan opened the door of his office and invited He Jianyi in.

He Jianyi sat down and said with some concern:"Do you know Director Zhao Lei from the hospital's Human Resources Department? Zhao Lei was a classmate of Liu Huimin and me in college. She is the director of the Human Resources Department and is one level older than Liu Huimin and me."

"Zhao Lei's husband is the general manager of Huiwei Pharmaceutical Group. He is the person in charge of Huiwei Pharmaceutical Group. His name is Fang Zhijun. He bribed my ex-wife Mei Lan to get me to sign."

"Fang Zhijun thought that I would sign because Mei Lan is my ex-wife. How naive... I will never help Huiwei Pharmaceutical Group cover up the ugly truth!"

Zhou Yuan nodded and asked,"How is the progress at the Food and Drug Administration?"

It is unlikely to expose and report Huiwei Pharmaceutical Group's new thrombolytic drug to the Food and Drug Administration. This new drug is backed by billions of dollars in profits. Such a generous return is enough to clear all obstacles on the road to listing.

"It is still under review. I estimate that in three months at most, this new type of thrombolytic drug will appear on the market, and the price is estimated to be between several thousand and ten thousand."

Of course, those doctors who agree to modify their signatures on the expert certification may get a much cheaper price, estimated to be around one thousand.

This is an extremely tempting condition. A box of medicine costs five or six thousand, seven or eight thousand. According to the patient flow of the hospital, the amount of medicine produced is extremely terrifying.……

"It is indeed very tempting."Zhou Yuan sighed.

The cost of the medicine is not worth so much money, at most a few hundred yuan, but once it is made into medicine, it is common for the price to increase several times or even dozens of times.

Because researching a new drug is time-consuming and costly, the research cycle is long, and the investment is extremely huge.

Take Gleevec, which can treat chronic myeloid leukemia that Haoyue suffers from. Before the emergence of Gleevec, humans were almost helpless against chronic myeloid leukemia. Apart from waiting for a bone marrow transplant or enduring the extremely painful interference of chemotherapy, there was only one way out. However, Novartis, a Swiss company, spent five years on the research of Gleevec.

For ten years, a large number of experts have devoted their lives to the research of Gleevec. Finally, after spending more than 5 billion US dollars, Gleevec was born.

This drug has turned chronic myeloid leukemia, which can only wait for death, into a disease that can be controlled by drugs like hypertension and diabetes. As long as they take Gleevec, chronic myeloid leukemia patients can live like ordinary people.

Therefore, those who cannot wait for a bone marrow transplant can use Gleevec to prolong their lives.

But... a box of Gleevec costs as much as 25,000 yuan!

It is also a drug that needs to be taken for a long time. It is a life-saving drug, so ordinary people simply cannot afford it.

Do you say that it is priced high and outrageous?

However, the development and manufacture of Gleevec has consumed the efforts of countless experts. For fifty years, countless expert teams have worked day and night to tackle the problem, and have spent more than 5 billion US dollars...

If the price of the drug is not high, how can these costs be recovered?

Pharmaceutical companies are not charities, and experts are not saints. Without the drive of profit, no one will spend energy to research new drugs. Without new drugs, the victims will still be the patients waiting for new drugs.

These pharmaceutical companies are like buying lottery tickets. If the research and development If the drug is successfully launched, then they can make a lot of money. However, if there is no progress after decades of research... it is equivalent to all the investment going down the drain.

Back to Huiwei Pharmaceutical Group, the same is true.

To develop a new type of thrombolytic drug, Huiwei Pharmaceutical Group invested a large number of experts and spent more than one billion.

If the drug is successfully launched, then Huiwei Pharmaceutical Group can make billions of profits. However, if the new type of thrombolytic drug dies in the end and is stopped by the Food and Drug Administration, they will suffer a loss of more than one billion, and this is not to mention the research and development efforts of a large group of experts..._

Feilu reminds you: Three things to do when reading - collect, recommend, and share